- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05680168
Efficacy of Extracorporeal Magnetic Stimulation, Pelvic Floor Muscle Exercise, and Combination of Both in Management of Post Radical Prostatectomy Urinary Incontinence
January 11, 2023 updated by: Ahmed Albakr, Hamad General Hospital
Efficacy of Extracorporeal Magnetic Stimulation, Pelvic Floor Muscle Exercise, and Combination of Both in Management of Post Radical Prostatectomy Urinary Incontinence: A Randomized Controlled Trial
Urinary incontinence is one of the most common complications of radical prostatectomy.
Multiple prevention and treatment modalities have been proposed in the management of post prostatectomy urinary incontinence.
This is a randomized controlled comparative study to evaluate the efficacy of extracorporeal magnetic stimulation alone and combined with pelvic floor muscle exercise versus pelvic floor muscle exercise alone in the management of post radical prostatectomy urinary incontinence.
This study is expected to be performed over 7 years.
The study population will be all male patients who are prepared for radical prostatectomy under urology department in HMC and were referred to voiding dysfunction for preoperative counselling and postoperative rehabilitation.
Patients will be randomized into one of three treatment groups.
The first group will receive sessions of extracorporeal magnetic field stimulation only.
The second group will receive extracorporeal magnetic stimulation in addition to pelvic floor muscle exercise.
The third group will receive pelvic floor muscle exercise only.
The recruitment phase will take 3 years.
Patients will be followed for 18 months for the course of urinary incontinence symptoms, severity of urinary incontinence on 1-hour pad test, urodynamic leak point pressure and the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF) and the ICIQ quality of life (QOL) score.
This study is proposed to reveal strong evidence on the efficacy of extracorporeal magnetic stimulation on the management of post radical prostatectomy urinary incontinence.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ahmed Albakr
- Phone Number: 974 33757500
- Email: aalbakr3@hamad.qa
Study Contact Backup
- Name: Ardalan Ghafouri
- Email: aghafouri@hamad.qa
Study Locations
-
-
-
Doha, Qatar
- Recruiting
- Ambulatory Care Center
-
Contact:
- Ahmed Albakr
- Phone Number: 00974 33757500
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- The study population will include all adult male patients 18 years of age and above, with localized prostate cancer of low or intermediate risk disease who chose definitive treatment with radical prostatectomy either through open radical retropubic prostatectomy (RRP) or through robotic assissted laparoscopic radical prostatectomy (RALP) as first line for treatment and had the surgery under Hamad General Hospital urology department care.
Exclusion Criteria:
- Patients with high risk , locally advanced or metastatic prostate cancer at time of diagnosis
- Patients with low to intermediate risk prostate cancer who received chemo or radiotherapy then had salvage surgery
- Patients with urinary incontinence or diagnosed overactive bladder before radical prostatectomy.
- Patients with complicated surgery resulting in anastomotic leak, prolonged catheterisation more than 3 weeks, reinsertion of catheter due to retention of urine.
- Patients who refuse to participate in the clinical trial.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Group A: Extracorporeal Magnetic stimulation
Group (A): will receive rehabilitation program with exposure to ExMS, Patients will receive regular sessions of electromagnetic stimulation using Magneto STYM device, (Iskra medical d.o.o, Slovenia).
Each session will last for 20 minutes.
Patients will receive three weekly sessions for total of 20 sessions starting one month after catheter removal.
|
Electromagnetic stimulation using Magneto STYM device, (Iskra medical d.o.o, Slovenia).
|
|
Active Comparator: Group B: Extracorporeal Magnetic stimulation and pelvic floor exercises
Group (B): This group will receive a rehabilitation program depending ExMS with the protocol described above.
In addition, this group will be advised for pelvic floor muscle training in serial training sessions with our therapist for PME.
|
Electromagnetic stimulation using Magneto STYM device, (Iskra medical d.o.o, Slovenia).
Pelvic floor muscle training in serial training sessions with our therapist
|
|
Active Comparator: Group C: Pelvic floor exercises
Group (C): This will be the control group.
This group will be advised to do PME only.
The pelvic floor exercises will consist of advice to the patients to contract the anal sphincter muscles in successive way as if holding flatus.
The pelvic floor muscle training schedule and therapist in group B and group C will be the same.
|
Pelvic floor muscle training in serial training sessions with our therapist
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
One hour pad test
Time Frame: 18 months from the start of intervention
|
Measuring the weight of an incontinence pad used for one hour to detect the volume of urinary leakage in one hour assessed at 6 points of follow up
|
18 months from the start of intervention
|
|
the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF)
Time Frame: 18 months from the start of intervention
|
Questionnaire administered at 6 points of follow up
|
18 months from the start of intervention
|
|
Urodynamic leak point pressure.
Time Frame: 1 day (Once) after 6 weeks of the start of rehabilitation process
|
Urodynamic study to evaluate the bladder dynamics and its response to radical prostatectomy and its response to rehabilitation
|
1 day (Once) after 6 weeks of the start of rehabilitation process
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
International Consultation on Incontinence Questionnaire quality of life score
Time Frame: 18 months from the start of intervention
|
Questionnaire administered at 6 points of follow up
|
18 months from the start of intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2023
Primary Completion (Anticipated)
February 1, 2029
Study Completion (Anticipated)
December 31, 2029
Study Registration Dates
First Submitted
December 15, 2022
First Submitted That Met QC Criteria
January 10, 2023
First Posted (Actual)
January 11, 2023
Study Record Updates
Last Update Posted (Estimate)
January 13, 2023
Last Update Submitted That Met QC Criteria
January 11, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MRC0122185
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post Radical Prostatectomy Urinary Incontinence
-
Hacettepe UniversityNot yet recruitingErectile Dysfunction Following Radical Prostatectomy | Post Prostatectomy Incontinence
-
Mansoura UniversityCompleted
-
Giresun UniversityRecruitingErectile Dysfunction Following Radical Prostatectomy | Urinary Incontinence (UI) | Prostate Cancer (Post Prostatectomy)Turkey (Türkiye)
-
Ilsan Cha hospitalCompletedRobot-Assisted Radical ProstatectomySouth Korea
-
Regional Hospital West JutlandRecruitingIncontinence, Urinary | Radical ProstatectomyDenmark
-
Copenhagen University Hospital at HerlevRigshospitalet, DenmarkUnknownUrinary Incontinence | Radical ProstatectomyDenmark
-
Yonsei UniversityCompletedRobotic-assisted Laparoscopic Radical ProstatectomyKorea, Republic of
-
Comphya Inc.RecruitingErectile Dysfunction Following Radical ProstatectomyUnited States
-
Yonsei UniversityCompletedRobot-Assisted Laparoscopic Radical ProstatectomyKorea, Republic of
-
University College, LondonRecruitingRadical Prostatectomy | Erectile Dysfunction Following Radical Prostatectomy | Erectile Dysfunction Due to Arterial Insufficiency | Robotic Radical ProstatectomyUnited Kingdom
Clinical Trials on Extracorporeal electromagnetic stimulation
-
Benha UniversityBeni-Suef UniversityRecruitingPelvic Floor Muscle Training | Female Sexual Dysfunction (FSD) | Shock Wave | Pulsed Electromagnetic TherapyEgypt
-
Samsung Medical CenterCompletedUrinary Stress IncontinenceKorea, Republic of
-
Charite University, Berlin, GermanyStimit AGCompletedMuscle Weakness | General AnaesthesiaGermany
-
Charite University, Berlin, GermanyStimit AGCompletedMuscle Weakness | General AnaesthesiaGermany
-
Samsung Medical CenterM-cube technologyCompletedChronic Prostatitis | Chronic Pelvic Pain SyndromeKorea, Republic of
-
Fundacion Clinica Valle del LiliCompletedFracture, Closed, Comminuted, HealingColombia
-
Charite University, Berlin, GermanyStimit AGTerminatedCritical Illness | Muscle Weakness | Mechanical Ventilation ComplicationGermany
-
Sydney South West Area Health ServiceSt George Hospital, Australia; University of Wollongong; South West Sydney Local... and other collaboratorsUnknown
-
Thomas NiederhauserBern University of Applied Sciences; Swiss Paraplegic Research, NottwilRecruiting
-
Cedars-Sinai Medical CenterNot yet recruiting